Variant report

Variant	nsv537986
Chromosome Location	chr5:179818116-179869311
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:295)
CpG islands
(count:184)
Chromatin interactive
region (count:13)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:295 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:179839178-179839187	K562	blood:	n/a	n/a
2	BCL3	chr5:179868437-179868959	A549	lung:	n/a	n/a
3	BHLHE40	chr5:179817911-179818150	K562	blood:	n/a	n/a
4	BRCA1	chr5:179868488-179868947	Hela-S3	cervix:	n/a	n/a
5	CBX3	chr5:179826497-179826928	K562	blood:	n/a	n/a
6	CEBPB	chr5:179850048-179850522	ECC-1	luminal epithelium:	n/a	chr5:179850243-179850254
7	CEBPB	chr5:179868693-179868804	HepG2	liver:	n/a	n/a
8	CEBPB	chr5:179822585-179822785	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr5:179868475-179869025	A549	lung:	n/a	n/a
10	CEBPB	chr5:179868457-179868942	A549	lung:	n/a	n/a
11	CEBPB	chr5:179868564-179868939	HepG2	liver:	n/a	n/a
12	CEBPB	chr5:179818791-179819004	A549	lung:	n/a	chr5:179818916-179818927
13	CEBPB	chr5:179818852-179819052	HepG2	liver:	n/a	chr5:179818916-179818927
14	CEBPB	chr5:179868404-179869008	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr5:179868509-179869066	ECC-1	luminal epithelium:	n/a	n/a
16	CEBPB	chr5:179818852-179818945	Hela-S3	cervix:	n/a	chr5:179818916-179818927
17	CEBPB	chr5:179868614-179868802	K562	blood:	n/a	n/a
18	CEBPB	chr5:179868503-179868981	A549	lung:	n/a	n/a
19	CEBPB	chr5:179868558-179868900	ECC-1	luminal epithelium:	n/a	n/a
20	CEBPB	chr5:179818848-179819010	IMR90	lung:	n/a	chr5:179818916-179818927
21	CEBPB	chr5:179868644-179868876	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr5:179850146-179850425	Hela-S3	cervix:	n/a	chr5:179850243-179850254
23	CEBPB	chr5:179850225-179850289	HepG2	liver:	n/a	chr5:179850243-179850254
24	CEBPB	chr5:179822205-179822723	A549	lung:	n/a	n/a
25	CEBPB	chr5:179850187-179850335	A549	lung:	n/a	chr5:179850243-179850254
26	CEBPB	chr5:179836720-179836786	K562	blood:	n/a	n/a
27	CEBPB	chr5:179868606-179868934	HepG2	liver:	n/a	n/a
28	CEBPB	chr5:179850023-179850574	ECC-1	luminal epithelium:	n/a	chr5:179850243-179850254
29	CHD2	chr5:179826608-179826889	K562	blood:	n/a	n/a
30	CHD2	chr5:179868545-179869128	Hela-S3	cervix:	n/a	n/a
31	CHD2	chr5:179826603-179826833	HepG2	liver:	n/a	n/a
32	CREB1	chr5:179868595-179868944	A549	lung:	n/a	n/a
33	CTCF	chr5:179867385-179867685	H1-hESC	embryonic stem cell:	n/a	n/a
34	CTCF	chr5:179867484-179867676	HepG2	liver:	n/a	n/a
35	CTCF	chr5:179817742-179818319	HCT-116	colon:	n/a	chr5:179817786-179817799
36	CTCF	chr5:179867524-179867599	Fibrobl	skin:	n/a	n/a
37	CTCF	chr5:179841146-179841303	K562	blood:	n/a	n/a
38	CTCF	chr5:179867460-179867610	HBMEC	blood vessel:	n/a	n/a
39	CTCF	chr5:179867523-179867695	HepG2	liver:	n/a	n/a
40	CTCF	chr5:179867500-179867650	HAc	cerebellar:	n/a	n/a
41	CTCF	chr5:179832882-179833003	GM20000	blood:	n/a	n/a
42	CTCF	chr5:179841240-179841390	MCF-7	breast:	n/a	n/a
43	CTCF	chr5:179821338-179821536	K562	blood:	n/a	n/a
44	CTCF	chr5:179817953-179818118	K562	blood:	n/a	n/a
45	CTCF	chr5:179867578-179867582	Medullo	brain:	n/a	n/a
46	CTCF	chr5:179839018-179839058	LNCaP	prostate:	n/a	n/a
47	CTCF	chr5:179841100-179841250	HEK293	kidney:	n/a	n/a
48	CTCF	chr5:179841084-179841399	MCF-7	breast:	n/a	n/a
49	CTCF	chr5:179841199-179841317	MCF-7	breast:	n/a	n/a
50	CTCF	chr5:179857665-179857815	HepG2	liver:	n/a	n/a

(count:184 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:179868587-179868637	GM12891	blood:	n/a
2	chr5:179868587-179868637	GM12891	blood:	n/a
3	chr5:179859512-179859562	HRCEpiC	kidney:	n/a
4	chr5:179868587-179868637	A549	lung:	n/a
5	chr5:179859512-179859562	H1-hESC	embryonic stem cell:	embryo
6	chr5:179868587-179868637	SK-N-MC	brain:	n/a
7	chr5:179859344-179859394	HCT-116	colon:	n/a
8	chr5:179859344-179859394	SK-N-SH	brain:	n/a
9	chr5:179868587-179868637	SK-N-SH_RA	brain:	n/a
10	chr5:179859512-179859562	AG10803	skin:	n/a
11	chr5:179859344-179859394	GM12891	blood:	n/a
12	chr5:179868587-179868637	MCF10A-Er-Src	breast:	n/a
13	chr5:179859344-179859394	AG04450	lung:	fetal
14	chr5:179859512-179859562	SAEC	small airway:	n/a
15	chr5:179859344-179859394	SAEC	small airway:	n/a
16	chr5:179859344-179859394	ovcar-3	ovarian:	n/a
17	chr5:179859344-179859394	AG04449	skin:	fetal
18	chr5:179859512-179859562	BJ	skin:	n/a
19	chr5:179859512-179859562	HEEpiC	esophagus:	n/a
20	chr5:179859344-179859394	AG09309	skin:	n/a
21	chr5:179859512-179859562	T-47D	breast:	n/a
22	chr5:179868587-179868637	HRPEpiC	eye:	n/a
23	chr5:179859344-179859394	HUVEC	blood vessel:	n/a
24	chr5:179859344-179859394	HMEC	breast:	n/a
25	chr5:179859512-179859562	HRPEpiC	eye:	n/a
26	chr5:179868587-179868637	Caco-2	colon:	n/a
27	chr5:179859344-179859394	BJ	skin:	n/a
28	chr5:179868587-179868637	GM19239	blood:	n/a
29	chr5:179859512-179859562	HRE	kidney:	n/a
30	chr5:179859512-179859562	HL-60	blood:	n/a
31	chr5:179868587-179868637	HNPCEpiC	eye:	n/a
32	chr5:179859344-179859394	GM19239	blood:	n/a
33	chr5:179868587-179868637	HCM	heart:	n/a
34	chr5:179859344-179859394	PANC-1	pancreas:	n/a
35	chr5:179868587-179868637	ECC-1	luminal epithelium:	n/a
36	chr5:179868587-179868637	AG10803	skin:	n/a
37	chr5:179868587-179868637	HMEC	breast:	n/a
38	chr5:179868587-179868637	H1-hESC	embryonic stem cell:	embryo
39	chr5:179868587-179868637	HRCEpiC	kidney:	n/a
40	chr5:179859512-179859562	HUVEC	blood vessel:	n/a
41	chr5:179859512-179859562	ECC-1	luminal epithelium:	n/a
42	chr5:179859512-179859562	CMK	blood:	n/a
43	chr5:179868587-179868637	SK-N-SH	brain:	n/a
44	chr5:179859344-179859394	Hepatocyte	liver:	n/a
45	chr5:179859512-179859562	AoSMC	blood vessel:	n/a
46	chr5:179859344-179859394	RPTEC	kidney:	n/a
47	chr5:179868587-179868637	LNCaP	prostate:	n/a
48	chr5:179859344-179859394	NH-A	brain:	n/a
49	chr5:179859512-179859562	A549	lung:	n/a
50	chr5:179859512-179859562	NT2-D1	testis:	n/a

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:179850450..179853162-chr5:179855103..179857524,2	K562	blood:
2	chr5:179850803..179853162-chr5:179854967..179857524,2	K562	blood:
3	chr5:179817994..179819684-chr5:179863109..179865015,2	MCF-7	breast:
4	chr5:179861530..179864602-chr5:179865007..179869137,4	MCF-7	breast:
5	chr5:179850803..179853162-chr5:179854967..179857524,2	K562	blood:
6	chr5:179862809..179864746-chr5:179865853..179867596,2	K562	blood:
7	chr5:179841196..179841781-chr5:179897664..179898357,3	MCF-7	breast:
8	chr5:179817994..179819684-chr5:179863109..179865015,2	MCF-7	breast:
9	chr5:179862165..179864527-chr5:179866069..179868577,2	MCF-7	breast:
10	chr5:179850450..179853162-chr5:179855103..179857524,2	K562	blood:
11	chr5:179862809..179864746-chr5:179865853..179867596,2	K562	blood:
12	chr5:179864826..179867133-chr5:179867279..179868980,2	K562	blood:
13	chr17:31149444..31150236-chr5:179865944..179866444,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CNOT6-2	chr5:179868559-179868855	XLOC_004679

No data

Variant related genes	Relation type
RNU6-525P	TF binding region
ENSG00000250509	TF binding region
RNU6-525P	CpG island
ENSG00000250509	CpG island
ENSG00000250509	chromatin interactions
ATXN1L	miRNA target sites

Extended variants
information (count: 1938 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:1938 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs141772093	chr5:179818129-179818130	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs551458173	chr5:179818180-179818181	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs6601120	chr5:179818199-179818200	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs561691620	chr5:179818207-179818208	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs4700949	chr5:179818208-179818209	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs6601121	chr5:179818227-179818228	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs542089104	chr5:179818234-179818235	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs147196448	chr5:179818257-179818258	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs527589618	chr5:179818269-179818270	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs371712954	chr5:179818294-179818295	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs6601122	chr5:179818333-179818334	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs190226138	chr5:179818440-179818441	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs140463384	chr5:179818462-179818463	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs181564222	chr5:179818484-179818485	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs370532696	chr5:179818492-179818493	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs533341636	chr5:179818501-179818502	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs375276933	chr5:179818515-179818516	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs79484757	chr5:179818516-179818517	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs185859710	chr5:179818542-179818543	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs570160902	chr5:179818548-179818549	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs565991830	chr5:179818551-179818552	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs535002543	chr5:179818556-179818557	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs75091672	chr5:179818568-179818569	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs147482994	chr5:179818569-179818570	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs370115802	chr5:179818590-179818591	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs374335066	chr5:179818598-179818599	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs114581961	chr5:179818618-179818619	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs74450946	chr5:179818654-179818655	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs576105746	chr5:179818681-179818682	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs569145526	chr5:179818687-179818688	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs536116073	chr5:179818719-179818720	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs139274950	chr5:179818745-179818746	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs566047828	chr5:179818747-179818748	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs368734835	chr5:179818761-179818762	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs78941711	chr5:179818776-179818777	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs541307900	chr5:179818834-179818835	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs535044475	chr5:179818846-179818847	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs116699545	chr5:179818853-179818854	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs149979604	chr5:179818864-179818865	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs7733582	chr5:179818868-179818869	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs7719158	chr5:179818920-179818921	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs537551851	chr5:179818921-179818922	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs76759969	chr5:179818927-179818928	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs201615679	chr5:179818937-179818938	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs34937381	chr5:179818938-179818939	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs77910584	chr5:179818941-179818942	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs549130487	chr5:179818943-179818944	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs559543485	chr5:179818946-179818947	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs528688815	chr5:179818950-179818951	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs190272948	chr5:179818955-179818956	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
small cell lung cancer	20016488	CNVD
Autism	22543975	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:114 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:179817000-179818800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr5:179817800-179818400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
3	chr5:179817800-179821000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr5:179818600-179818800	Bivalent Enhancer	Placenta	Placenta
5	chr5:179818800-179819000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr5:179819000-179821400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr5:179821000-179821600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr5:179821600-179822600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr5:179822000-179822200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr5:179822000-179823400	Enhancers	Fetal Muscle Trunk	muscle
11	chr5:179822200-179822400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr5:179822400-179822600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr5:179822400-179823000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr5:179822400-179823200	Enhancers	Fetal Muscle Leg	muscle
15	chr5:179822600-179822800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr5:179822600-179822800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr5:179822600-179823000	Enhancers	A549	lung
18	chr5:179822800-179823000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr5:179822800-179826400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr5:179823000-179826400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr5:179823400-179824000	Weak transcription	Fetal Muscle Trunk	muscle
22	chr5:179824000-179824200	Enhancers	Fetal Muscle Trunk	muscle
23	chr5:179824000-179824400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr5:179824200-179826200	Weak transcription	Fetal Muscle Trunk	muscle
25	chr5:179824200-179826400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
26	chr5:179826200-179827600	Enhancers	Fetal Muscle Leg	muscle
27	chr5:179826200-179827800	Enhancers	Fetal Muscle Trunk	muscle
28	chr5:179826400-179826800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr5:179826400-179827200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr5:179826400-179827600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr5:179827200-179827400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr5:179827200-179827800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
33	chr5:179827400-179827800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr5:179827800-179832400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr5:179840200-179841200	Enhancers	Placenta	Placenta
36	chr5:179840400-179840800	Active TSS	Hela-S3	cervix
37	chr5:179843600-179844200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
38	chr5:179845600-179846200	Active TSS	H9 Cell Line	embryonic stem cell
39	chr5:179846000-179846400	Active TSS	ES-I3 Cell Line	embryonic stem cell
40	chr5:179846400-179850600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
41	chr5:179849800-179850400	Enhancers	Brain Substantia Nigra	brain
42	chr5:179849800-179850800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr5:179849800-179851200	Enhancers	Hela-S3	cervix
44	chr5:179850200-179850600	Enhancers	Brain Hippocampus Middle	brain
45	chr5:179850200-179851000	Enhancers	Breast Myoepithelial Primary Cells	Breast
46	chr5:179850200-179851400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
47	chr5:179850400-179851000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr5:179850400-179851400	Enhancers	A549	lung
49	chr5:179850600-179851200	Enhancers	ES-I3 Cell Line	embryonic stem cell
50	chr5:179850600-179851400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links